Minnesota SF 272: Price gouging by drug manufacturer or wholesale distributor prohibition; pharmacy board, human services commissioner and health plan companies notification of prescription drug price increases to the attorney general authorization; attorney general drug pricing information access and action against drug manufacturers and wholesalers authorization; civil penalties imposition

Status: Author added Newton (as of 2019-01-28)

State: Minnesota · Session: 2019-2020 · Bill: SF 272

Subjects: Consumer Protection, Drugs and Medicine, Human Services and Human Services Department, Insurance-Health

Sponsors: Klein, Little, Marty, Newton

View Minnesota SF 272 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.